To explain the association of high C3 levels in plasma, brain parenchyma, and CSF with AD and AS, multiple mouse studies have examined the effects of C3 and its activation products and CR3 or C3aR by breeding transgenic or knock-out mice or pharmacologically blocking the corresponding receptors. The gene discussed is C3; the disease is Alzheimer disease.